Product Highlight - Lixiana

29 Sep 2021
• Proven efficacy vs warfarin1-3
• Superior reduction in major bleeding vs warfarin1-3
• Proven efficacy and safety in patients’ dose-reduced to 30 mg1-3
• 24 hours anticoagulation1,4
• Once daily with or without food1,4
• Simple and convenient dosing across all indications1-3

References:
1. LIXIANA® Summary of Product Characteristics, May 2020.
2. Giugliano RP et al. N Engl J Med 2013;369(22):2093–104.
3.
Giugliano RP et al. N Engl J Med 2013;369(22):Supplementary Appendix.
4. Bathala MS et al. Drug Metab Dispos 2012;40(12):2250-55.


Related MIMS Drugs

Editor's Recommendations